Editas Medicine to Provide Broad Institute With up to $125M in CRISPR Funding

Jun 11, 2018

|

NEW YORK (GenomeWeb) — CRISPR-based therapeutics developer Editas Medicine has agreed to provide up to $125 million in research funding to the Broad Institute in exchange for the exclusive right to be the first to negotiate for licenses to genome-editing inventions that arise from the sponsored research.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Closely Intertwined

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Little From Here and There

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

This Week in Science

In Science this week: in vitro generation of human reproductive cells, and more.

All the Arms for Hugging

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

Main menu